Acetylon Pharmaceuticals acetylon.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platform has yielded a portfolio of optimized, orally-administered Class I and Class II histone deacetylase (HDAC) selective compounds. Alteration of HDAC regulation through selective HDAC inhibition is thought to be applicable to a broad range of diseases ...Show all

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platfor...Show all

Company (Acquired)

Phone: 617-245-1300

Fax:

70 Fargo Street
Suite 205
Boston, 02210
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acetylon Pharmaceuticals $156.1M Dec 2, 2016
Xanthus Pharmaceuticals $63.8M Jun 9, 2008
HNC Software $0M May 2, 2002
See all 37 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acetylon Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 37 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combinations of histone deacetylase inhibitors and immunomodulatory drugs Dec 03, 2014 Apr 24, 2018 Patent
Pyrimidine hydroxy amide compounds as hdac6 selective inhibitors Sep 09, 2016 Feb 06, 2018 Patent
Treatment of leukemia with histone deacetylase inhibitors Jul 06, 2015 Dec 05, 2017 Patent
Piperidine derivatives as hdac1/2 inhibitors Dec 11, 2015 Oct 17, 2017 Patent
Selective hdac1 and hdac2 inhibitors Jul 19, 2016 Sep 19, 2017 Patent
See all 39 patents